Transcript 슬라이드 1 - the Paran

About Quro
Pipeline
Organization
News
Contact
Home
Site Map
INNOVATION IN INFECTIOUS DISEASES TREATMENT
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
Quro Science Inc.
Quro is a spin-off biotechnology company from Institut Pasteur Korea (IP-K) committed to develop novel therapeutics against infectious diseases.
Quro’s main focus is on human immunodeficiency virus (HIV), hepatitis C virus (HCV) and tuberculosis (TB) infection. Quro has exclusive rights
to develop and commercialize drug candidates discovered with IP-K’s proprietary state-of-the-art technologies including the PhenomicScreenTM
and PhenomicIDTM platforms. Quro has in-house expertise in preclinical and clinical development management and operates as a virtual company
using contract research organizations (CROs) for execution of the development works. Quro intends to license out the products in the course of
the clinical development to larger partners for further development.
About Quro
Pipeline
Organization
Quro’s Operations Model
News
Contact
Home
Site Map
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
About Quro
Pipeline
Organizational Chart
Organization
News
Contact
Home
Site Map
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
Management Team
Dr. Ulf Nehrbass, CEO
Dr. Nehrbass graduated in Biochemistry from Cambridge University, UK, and obtained his Ph.D. at the EMBL
in Heidelberg, Germany in 1992. After a postdoctoral position in the Howard Hughes Medical Institute at the
Rockefeller University, New York, he joined the Institut Pasteur in Paris, in 1998 where he was Head of the
Nuclear Cell Biology unit and CNRS Research Director. After a number of research awards he was elected
member of EMBO in 2005. He has been CEO of IP-Korea since its inception in 2004.
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
Board of Directors
Dr. Ulf Nehrbass
Head of the Nuclear Cell Biology unit, Institut Pasteur in Paris
CNRS Research Director
CEO of Institut Pasteur Korea
Dr. Yung Bog Chae
Chairman of Institut Pasteur Korea Board of Directors
Chairman of Gyeonggi Bio-Center
Former Minister, Ministry of Science and Technology, Republic of Korea
Mr. Seok Won Yoon
General Manager, Hanwha Venture Capital Corp.
Director, Green & Biotech, Inc.
General Manager, Basic Venture Capital, Co., Ltd
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
Board of Directors
Dr. Yongmo Lee
Director, Center for International Cooperation, National Research Foundation
Associate Professor,
Dr. Myung Whan Park
Director of Gyeonggi Bio-Center
External Auditor
Dr. Jae Whan Park
Professor, Department of Business and Management School
Of Social Science, Chung-Ang University
About Quro
Pipeline
Organization
News
Contact
Bulletin board here
Home
Site Map
About Quro
Pipeline
Organization
News
Contact
Home
Site Map
Quro Science Inc.
Sampyeong-dong 696
Bundang-gu Seongnam-si
Gyeonggi-do, Korea
Tel: +82-31-8018-8370
Fax: +82-31-8018-8380
[email protected]